Cochrane Abstracts
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism: Cochrane systematic review
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Once Versus Twice Daily Low Molecular Weight Heparin for the Initial Treatment of Venous Thromboembolism: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432152/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism:_Cochrane_systematic_review. Accessed 13 August 2022.
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432152/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism:_Cochrane_systematic_review. Accessed August 13, 2022.
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432152/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism:_Cochrane_systematic_review
Once Versus Twice Daily Low Molecular Weight Heparin for the Initial Treatment of Venous Thromboembolism: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2022 August 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432152/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism: Cochrane systematic review
ID - 432152
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432152/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
